El-Rabat, K., Hamouda, M., El-Nagar, A., Salim, M. (2021). Clinical and Angiographic Predictors of No-Reflow Phenomenon during Primary Percutaneous Coronary Intervention. Benha Journal of Applied Sciences, 6(1), 267-272. doi: 10.21608/bjas.2021.169124
K.A. El-Rabat; M.A. Hamouda; A.E. El-Nagar; M.E. Salim. "Clinical and Angiographic Predictors of No-Reflow Phenomenon during Primary Percutaneous Coronary Intervention". Benha Journal of Applied Sciences, 6, 1, 2021, 267-272. doi: 10.21608/bjas.2021.169124
El-Rabat, K., Hamouda, M., El-Nagar, A., Salim, M. (2021). 'Clinical and Angiographic Predictors of No-Reflow Phenomenon during Primary Percutaneous Coronary Intervention', Benha Journal of Applied Sciences, 6(1), pp. 267-272. doi: 10.21608/bjas.2021.169124
El-Rabat, K., Hamouda, M., El-Nagar, A., Salim, M. Clinical and Angiographic Predictors of No-Reflow Phenomenon during Primary Percutaneous Coronary Intervention. Benha Journal of Applied Sciences, 2021; 6(1): 267-272. doi: 10.21608/bjas.2021.169124
Clinical and Angiographic Predictors of No-Reflow Phenomenon during Primary Percutaneous Coronary Intervention
Cardiology Dept., Faculty of Medicine, Benha Univ., Benha, Egypt
Abstract
Foundation: Despite the new advancement in Percutaneous coronary mediation , an extent of patients create epicardial coronary course reperfusion without myocardial reperfusion after essential PCI, a wonder known as no-reflow . The point of this examination was to recognize conceivable clinical, angiographic and procedural indicators of no-reflow in patients with ST-section rise intense myocardial dead tissue after essential percutaneous coronary intercession. Subjects and strategies: This investigation included 100 patients who went through essential percutaneous coronary mediation . All patients were treated by uncovered metal stents limited to the guilty party injury just and platelets glycoprotein IIb/IIIa inhibitors were utilized after acknowledgment of coronary life structures as per the blood clot trouble degree and doctor discretion.Patients were characterized into two gatherings as indicated by the post-PCI TIMI stream grade: Group I included 84 patients with angiographically reported TIMI stream grade 3 (reflow) and Group II included 16 patients with angiographically recorded TIMI stream grade ≤ 2 (no-reflow) and were analyzed with respect to clinical, angiographic and procedural information long time from beginning of side effects to reperfusion, lower introductory TIMI stream grade, higher blood clot trouble on benchmark angiography, longer objective sore length and bigger reference luminal width. Results: Four investigations were incorporated from 2005 to 2014 with absolute cases 1169 cases 582 in clinical gathering and 587in fake treatment announced Complications after treatment . There was a measurably huge heterogeneity in the investigations (I2 69%, P 0.02). Utilizing the irregular impacts model, the result results uncovered that fake treatment was unimportantly not the same as clinical with respect to entanglements after treatment.there were three examinations included from 2014to 2019 with complete cases 362 cases 193 in Surgery with tube inclusion and 169 in without tube detailed Tympanic Membrane Normal after treatment . There was a measurably critical heterogeneity in the examinations (I2 87%, P 0.0005). Utilizing the irregular impacts model, the result results uncovered that Surgery with tube addition was unimportantly not quite the same as without tube with respect to Tympanic Membrane Normal after treatment.Conclusion: In the current examination no-reflow happened in 16.0 % of STEMI patients went through essential PCI and was bound to be identified with postponed reperfusion, low starting TIMI stream grade, high clots trouble, enormous reference luminal measurement and long sore length.